Amarantus Bioscience Holdings Inc (AMBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 10-2010 | 09-2010 | 07-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -503 | -1,208 | -59 | -487 | -43 |
| Depreciation Amortization | 7 | 6 | 1 | 4 | 1 |
| Accounts payable and accrued liabilities | 318 | 676 | N/A | 348 | 42 |
| Other Working Capital | 315 | 642 | 57 | 325 | 42 |
| Other Operating Activity | -251 | -656 | 0 | -509 | -42 |
| Operating Cash Flow | $-114 | $-539 | $0 | $-320 | $0 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7 | -30 | N/A | -28 | N/A |
| Investing Cash Flow | $-7 | $-30 | $N/A | $-28 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 86 | 225 | 1 | N/A | 1 |
| Debt Repayment | N/A | -100 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 490 | 0 | 450 | 0 |
| Financing Cash Flow | $86 | $615 | $1 | $450 | $1 |
| Beginning Cash Position | 48 | 1 | 0 | 1 | 0 |
| End Cash Position | 12 | 48 | 1 | 104 | 1 |
| Net Cash Flow | $-35 | $46 | $1 | $103 | $1 |
| Free Cash Flow | |||||
| Operating Cash Flow | -114 | -539 | 0 | -320 | 0 |
| Capital Expenditure | -7 | -30 | N/A | -28 | N/A |
| Free Cash Flow | -121 | -569 | 0 | -347 | 0 |